Back to News
Market Impact: 0.65

Phreesia Reports First Net Income Gain

PHRNDAQ
Corporate EarningsM&A & RestructuringCompany FundamentalsCorporate Guidance & OutlookArtificial IntelligenceTechnology & InnovationHealthcare & BiotechFintech
Phreesia Reports First Net Income Gain

Phreesia (NYSE:PHR) reported a landmark Q2 FY2026, achieving its first-ever net income positive quarter ($700k GAAP) with revenue up 15% and adjusted EBITDA reaching $22 million. Simultaneously, the company announced a transformative $160 million cash acquisition of AccessOne, a healthcare provider financing leader, expected to add $35 million in annualized revenue and expand Phreesia's payment solutions total addressable market by $6 billion. This strategic acquisition, combined with the positive financial milestone and raised adjusted EBITDA guidance for FY2026, positions Phreesia for broader health system market entry and accelerated profitable growth.

Analysis

Phreesia (PHR) has reported a pivotal second quarter for fiscal 2026, marked by two significant catalysts: achieving its first-ever GAAP net income and announcing the strategic acquisition of AccessOne. The shift to profitability, with a net income of $700,000, represents a major operational milestone, moving from a history of recurring losses. This was underpinned by strong fundamentals, including a 15% year-over-year revenue increase to $117.3 million and a substantial expansion in adjusted EBITDA to $22 million, representing a 19% margin. The growth is fueled by both client base expansion, with a net increase of 56 average healthcare services clients (AHSCs), and deeper client monetization, evidenced by a 7% YoY rise in revenue per AHSC to $26,249. Simultaneously, the $160 million cash acquisition of AccessOne is a transformative move set to significantly scale Phreesia's payments platform. The deal is projected to be immediately accretive, adding an estimated $35 million in annualized revenue and $11 million in adjusted EBITDA, while strategically expanding the company's total addressable market by $6 billion and strengthening its position within larger health systems. Management's confidence is further reflected in the raised full-year adjusted EBITDA guidance to between $87 million and $92 million, signaling sustained profitability even before the acquisition's contribution is factored in.

AllMind AI Terminal